Ethnic Differences in Maternal Adipokines during Normal Pregnancy.

about

Ethnic Differences in Maternal Adipokines during Normal Pregnancy.

Item

http://www.wikidata.org/entity/Q36512790

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Ethnic Differences in Maternal Adipokines during Normal Pregnancy.

@ast

Ethnic Differences in Maternal Adipokines during Normal Pregnancy.

@en

type

Item

label

Ethnic Differences in Maternal Adipokines during Normal Pregnancy.

@ast

Ethnic Differences in Maternal Adipokines during Normal Pregnancy.

@en

prefLabel

Ethnic Differences in Maternal Adipokines during Normal Pregnancy.

@ast

Ethnic Differences in Maternal Adipokines during Normal Pregnancy.

@en

P1476

Ethnic Differences in Maternal Adipokines during Normal Pregnancy.

@en

P2093

Theresa O Scholl

http://www.w3.org/2001/XMLSchema#string

Xinhua Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Adiponectin, driver or passenger on the road to insulin sensitivity?

Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women's Health Initiative

Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance.

Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome.

Insulin resistance in African-American and Caucasian women: differences in lipotoxicity, adipokines, and gene expression in adipose tissue and muscle.

Maternal ethnicity and pre-eclampsia in New York City, 1995-2003.

Disparities in the risk of gestational diabetes by race-ethnicity and country of birth.

Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study.

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes

P304

ijerph13010008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJERPH13010008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

288039154

http://www.w3.org/2001/XMLSchema#string

P698

26703679

http://www.w3.org/2001/XMLSchema#string

P932

4730399

http://www.w3.org/2001/XMLSchema#string